发明名称 |
HCV COMBINATION THERAPY |
摘要 |
Methods of treating patients having susceptible viral infections, especially chronic hepatitis C infection by administering to said patient a therapeutically effective amount of a combination therapy of interferon-alfa and ribavirin for a time sufficient to lower HCV-RNA in association with a therapeutically effective amount of an antioxidant for a time sufficient to ameliorate ribavirin-related hemolysis are disclosed.
|
申请公布号 |
CA2306039(A1) |
申请公布日期 |
2000.10.19 |
申请号 |
CA20002306039 |
申请日期 |
2000.04.18 |
申请人 |
SCHERING CORPORATION |
发明人 |
PIKEN, EDWARD;GLUE, PAUL W.;BRASS, CLIFFORD A. |
分类号 |
A61K31/01;A61K31/05;A61K31/07;A61K31/10;A61K31/122;A61K31/198;A61K31/355;A61K31/375;A61K31/7056;A61K33/04;A61K38/21;A61P7/06;A61P31/00;A61P31/12;A61P39/06;A61P43/00;(IPC1-7):A61K38/21;A61K45/08;A61K31/705 |
主分类号 |
A61K31/01 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|